BrightBid Group AB (publ) - Asset Resilience Ratio
BrightBid Group AB (publ) (PERP-B) has an Asset Resilience Ratio of 9.71% as of June 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of BrightBid Group AB (publ) for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2017)
This chart shows how BrightBid Group AB (publ)'s Asset Resilience Ratio has changed over time. See net assets of BrightBid Group AB (publ) for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down BrightBid Group AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see BrightBid Group AB (publ) market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 0% |
| Short-term Investments | Skr1.99 Million | 9.71% |
| Total Liquid Assets | Skr1.99 Million | 9.71% |
Asset Resilience Insights
- Limited Liquidity: BrightBid Group AB (publ) maintains only 9.71% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
BrightBid Group AB (publ) Industry Peers by Asset Resilience Ratio
Compare BrightBid Group AB (publ)'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085 |
Medical Devices | 7.69% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 34.47% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Imricor Medical Systems Inc
AU:IMR |
Medical Devices | 46.50% |
|
Lumos Diagnostics Holdings Ltd
AU:LDX |
Medical Devices | 14.18% |
|
MODULIGHT OY EO 1
F:78W |
Medical Devices | 18.04% |
Annual Asset Resilience Ratio for BrightBid Group AB (publ) (2017–2017)
The table below shows the annual Asset Resilience Ratio data for BrightBid Group AB (publ).
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2017-12-31 | 52.03% | Skr7.99 Million ≈ $860.14K |
Skr15.36 Million ≈ $1.65 Million |
-- |
About BrightBid Group AB (publ)
Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. The company provides DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the t… Read more